Molbio Diagnostics IPO Opens August 10 with Price Band of Rs 768-807
Molbio Diagnostics, a Goa-based molecular diagnostics company, is launching its initial public offering (IPO) from August 10 to 12, 2026, with a price band of Rs 768 to Rs 807 per share. The IPO aims to raise approximately Rs 940 crore through a fresh issue of Rs 200 crore and an offer for sale of Rs 740 crore by existing shareholders. Proceeds will support R&D, manufacturing expansion, and corporate purposes. The IPO includes a minimum lot size of 18 shares and has attracted strong grey market interest with a 21% premium.
First-hand measurement across 7 sources
We measured how 7 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (53/100). Lens Score 44/100.
Outlets measured: moneycontrol, economictimes, freepressjournal, timesnow, economictimes, news18, mint. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–62/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
mint broke this story on 5 Aug, 03:26 am. Other outlets followed.